Insider Transactions in Q4 2022 at Cerevel Therapeutics Holdings, Inc. (CERE)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 09 2022	N Anthony Coles	SELL Open market or private sale	Direct	50,000 -75.33%	$1,300,000 $26.86 P/Share
Dec 09 2022	N Anthony Coles	BUY Exercise of conversion of derivative security	Direct	50,000 +48.68%	$150,000 $3.5 P/Share
Nov 01 2022	John Renger Chief Scientific Officer	SELL Open market or private sale	Direct	25,000 -90.24%	$750,000 $30.0 P/Share
Nov 01 2022	John Renger Chief Scientific Officer	BUY Exercise of conversion of derivative security	Direct	25,000 +39.58%	$150,000 $6.89 P/Share
Oct 04 2022	John Renger Chief Scientific Officer	SELL Open market or private sale	Direct	25,000 -90.24%	$750,000 $30.0 P/Share
Oct 04 2022	John Renger Chief Scientific Officer	BUY Exercise of conversion of derivative security	Direct	25,000 +39.58%	$150,000 $6.89 P/Share

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Value

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

Operation

Value

Type

Receive news related to Cerevel Therapeutics Holdings, Inc.